Related Experiment Video
Updated: May 4, 2026

Synthesis of Cationized Magnetoferritin for Ultra-fast Magnetization of Cells
Published on: December 13, 2016
Activation of Src family tyrosine kinases by ferric ions
Graham S Baldwin1, Daisy Sio-Seng Lio2, Audrey Ferrand1
1The University of Melbourne Department of Surgery, Austin Health, Heidelberg, Victoria, Australia.
Abstract:
The Src-family tyrosine kinases (SFKs) are oncogenic enzymes that contribute to the initiation and progression of many types of cancer. In normal cells, SFKs are kept in an inactive state mainly by phosphorylation of a consensus regulatory tyrosine near the C-terminus (Tyr(530) in the SFK c-Src). As recent data indicate that tyrosine modification enhances binding of metal ions, the hypothesis that SFKs might be regulated by metal ions was investigated. The c-Src C-terminal peptide bound two Fe(3+) ions with affinities at pH4.0 of 33 and 252μM, and phosphorylation increased the affinities at least 10-fold to 1.4 and 23μM, as measured by absorbance spectroscopy. The corresponding phosphorylated peptide from the SFK Lyn bound two Fe(3+) ions with much higher affinities (1.2pM and 160nM) than the Src C-terminal peptide. Furthermore, when Lyn or Hck kinases, which had been stabilised in the inactive state by phosphorylation of the C-terminal regulatory tyrosine, were incubated with Fe(3+) ions, a significant enhancement of kinase activity was observed. In contrast Lyn or Hck kinases in the unphosphorylated active state were significantly inhibited by Fe(3+) ions. These results suggest that Fe(3+) ions can regulate SFK activity by binding to the phosphorylated C-terminal regulatory tyrosine.
Insights
Iron (Fe3+) ions regulate Src-family kinases (SFKs) by binding to their C-terminal tyrosine. Phosphorylation enhances this binding, modulating SFK activity in cancer progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Src-family kinases (SFKs) are key oncogenic enzymes in cancer.
- SFKs are typically inactivated by C-terminal tyrosine phosphorylation.
- Tyrosine modification may enhance metal ion binding.
Purpose of the Study:
- Investigate the hypothesis that metal ions regulate SFKs.
- Determine the effect of Fe(3+) on SFK activity.
Main Methods:
- Absorbance spectroscopy to measure peptide-metal ion binding.
- Assessing kinase activity of Lyn and Hck in the presence of Fe(3+).
Main Results:
- Phosphorylated SFK peptides bind Fe(3+) with high affinity.
- Fe(3+) enhances activity of inactive (phosphorylated) SFKs.
- Fe(3+) inhibits active (unphosphorylated) SFKs.
Conclusions:
- Fe(3+) ions regulate SFK activity.
- Regulation occurs via Fe(3+) binding to the phosphorylated C-terminal tyrosine.
- This provides a novel mechanism for SFK control in cancer.
More Related Videos
Related Concept Videos
Receptor Tyrosine Kinases
The Early Endosome: Endocytosis of Transferrin
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
MAPK Signaling Cascades
Intracellular Signaling Affects Focal Adhesions
Some...
PI3K/mTOR/AKT Signaling Pathway

